Free Float -
Shares Float -
Shares Outstanding 36,05 M
AEGIRBIO AB Share · SE0014401121 · A2P7ZC (XSTO) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AEGIRBIO AB
No Price
Share Float & Liquidity
Company Profile for AEGIRBIO AB Share
AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. The company was incorporated in 2019 and is based in Lund, Sweden.
Company Data
Name AEGIRBIO AB
Company AegirBio AB (publ)
Website
https://aegirbio.com
Primary Exchange 
NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
WKN A2P7ZC
ISIN SE0014401121
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO Marco Wititteveen
Market Capitalization 15 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Ideongatan 3A, 223 70 Lund
IPO Date 2020-06-26
Stock Splits
| Date | Split |
|---|---|
| 08.06.2022 | 1089:1000 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | AEGIR.ST |
| Frankfurt | 52Q.F |
More Shares
Investors who hold AEGIRBIO AB also have the following shares in their portfolio:
